Privacy masthead desktop

安全信息

重要的是要考虑 EVO Visian ICL (EVO) 已获得 FDA 批准,这意味着它已被确定为安全有效的程序。与任何手术一样,需要考虑风险,如果您有任何问题或疑虑,最好咨询经认证的 EVO Visian ICL 医生。请查看患者信息手册以获取完整信息。

Fa D desktop

用EVO ICL 解锁自由视界,您准备好了吗?立即查找医生

参考

1Patient Survey, STAAR Surgical ICL Data Registry, 2018

2Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46.

3Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

4Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

5aLee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

5bParkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

*American Refractive Surgery Council